These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 18163171

  • 1. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients.
    Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jeon DG.
    Ann Surg Oncol; 2008 Mar; 15(3):906-14. PubMed ID: 18163171
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth patterns of osteosarcoma predict patient survival.
    Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Shin DS, Jeon DG.
    Arch Orthop Trauma Surg; 2009 Sep; 129(9):1189-96. PubMed ID: 18682966
    [Abstract] [Full Text] [Related]

  • 4. Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis.
    Nathan SS, Gorlick R, Bukata S, Chou A, Morris CD, Boland PJ, Huvos AG, Meyers PA, Healey JH.
    Cancer; 2006 Oct 01; 107(7):1607-16. PubMed ID: 16933325
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations.
    Cho WH, Song WS, Jeon DG, Kong CB, Kim MS, Lee JA, Yoo JY, Kim JD, Lee SY.
    Ann Surg Oncol; 2010 Mar 01; 17(3):702-8. PubMed ID: 19921336
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Osteosarcoma developed in the period of maximal growth rate have inferior prognosis.
    Lee JA, Kim MS, Kim DH, Lim JS, Park KD, Song WS, Lee SY, Jeon DG.
    J Pediatr Hematol Oncol; 2008 Jun 01; 30(6):419-24. PubMed ID: 18525457
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.
    Jeon DG, Kong CB, Cho WH, Song WS, Cho SH, Choi SW, Lee SY.
    J Surg Oncol; 2014 Mar 01; 109(3):275-9. PubMed ID: 24243222
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis in pediatric osteosarcoma: impact of modern therapies.
    Hendershot E, Pappo A, Malkin D, Sung L.
    J Pediatr Oncol Nurs; 2006 Mar 01; 23(4):176-81. PubMed ID: 16766682
    [Abstract] [Full Text] [Related]

  • 14. [Poor prognosis of osteosarcoma of pelvis; 39 years of registration by the Netherlands Commission on Bone Tumors].
    Ham SJ, Kroon HM, Schraffordt Koops H, Hoekstra HJ.
    Ned Tijdschr Geneeskd; 2000 Jan 15; 144(3):121-5. PubMed ID: 10674118
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of increases in tumor volume after neoadjuvant chemotherapy on the outcome of stage II osteosarcoma regardless of histological response.
    Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, Yoo JY, Jung ST, Jeon DG.
    J Orthop Sci; 2009 May 15; 14(3):292-7. PubMed ID: 19499296
    [Abstract] [Full Text] [Related]

  • 19. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q, Niu XH, Cai YB, Hao L, Ding Y.
    Zhonghua Wai Ke Za Zhi; 2007 Aug 15; 45(16):1114-7. PubMed ID: 18005614
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.